In cancer, it's called electrochemical therapy, electrochemotherapy — when you combine the use
of a cancer drug, that you usually inject into the bloodstream, or you inject it directly into a tumor artery, and then you expose the body to this electrical field.
Last Friday, several news outlets reported that a study
of a cancer drug combination cocktail showed it didn't help melanoma patients live any longer, when compared to using one of the drugs alone.
Those specs might help a scientist standardize her experiments, but they may also be holding some research back for one type
of cancer drug, two St. Louis researchers argued in a recent review.
Men with aggressive prostate cancer that has stopped responding to conventional treatment could potentially benefit from a new class
of cancer drug designed to overcome drug resistance, a new study suggests.
In efforts to enhance pre-clinical drug testing, Thomas Gaddy of the University of Southern California, Los Angeles, and colleagues in the research group of Professor Stacey Finley investigated a potential predictive biomarker for a type
of cancer drug known as anti-angiogenic therapy.
It also may have helped several others by boosting the power of a new type
of cancer drug that uses a different mechanism to unleash an immune attack on the tumor.
Repurposed anticancer drugs such as aspirin and antacids may represent the future
of cancer drug research, according to leaders of the ReDO project.
The Knights had previously donated $ 100 million to create a cancer research institute at OHSU, headed by Brian Druker, who led the development
of the cancer drug Gleevec.
The numbers varied by medical specialty, with a full 80 %
of cancer drug approvals using these measurements.
In the case
of the cancer drug L - asparaginase type 2 (L - ASN2), whose primary effect is depleting asparagine, side effects are generally attributed to the corresponding depletion of a chemically similar molecule called glutamine.
The new eye studies showcase a drug called ranibizumab, which is a fragment
of the cancer drug.
But these repurposed anticancer drugs such as antifungals and painkillers may represent the future
of cancer drug research, according to leaders of the ReDO project.
When scientists reported 2 years ago that mice with certain gut bacteria responded best to a powerful new type
of cancer drug, other researchers were intrigued but cautious — mice, after all, aren't humans.
A new type
of cancer drug developed at Johns Hopkins University in Baltimore, Maryland, but not yet tested in clinical trials may have triggered the deaths of three patients who were undergoing an alternative cancer treatment by a nonmedical practitioner in Germany.
«Naturally occurring mechanism
of cancer drug - resistance may itself be a treatment target.»
Pfizer landed one of 2016's most sought - after biopharma deals with its $ 14 billion acquisition
of cancer drug maker Medivation, beating out the likes of Sanofi.
The company said a late - stage trial
of its cancer drug Abraxane met its main goal of improving the patient's time of survival without worsening skin cancer, when compared to standard chemotherapy.
The Food and Drug Administration (FDA) continued its potentially record - breaking pace of new drug approvals Thursday, green lighting the first - ever «biosimilar» copycat
of a cancer drug.
Now, here's a happy story: A combination of better screening, investments in drug research, and better lifestyle choices (including declines in cigarette smoking) may have helped lead to a downtick in the rate
of cancer drug deaths.
Drugmaker Merck reported a better - than - expected first - quarter profit on Tuesday, helped by a more than 150 percent rise in sales
of cancer drug Keytruda.
In a 564 - person trial, patients whose ovarian cancer recurred (and who had already started treatment with chemotherapy) given Rubraca, part of a new class
of cancer drugs called «PARP» inhibitors, lived, on median, for double the amount of time without their disease getting even worse compared with those given a placebo.
Kite Pharma, one of the companies chasing a new generation
of cancer drugs called chimeric antigen receptor T - cell (CAR - T) therapies, announced a patient death in a clinical trial of its experimental KTE - C19.
Researchers at Israel's Technion Institute of Technology are experimenting with a nanoparticle «barcode» system in order to trace the efficacy
of cancer drugs.
«The situation with the number
of cancer drugs on the market has improved since then,» Jensen said.
Roche, the world's biggest maker
of cancer drugs, had won fast - track approval last May in the United States for Tecentriq against bladder cancer but full approval hinged on further trials.
So if you're shocked by the six - figure prices
of cancer drugs that offer marginal health benefits, brace yourself for what's to come.
«Identities of Cabinet Ministers» Parliamentary Private Secretaries begin to emerge Main Cameron promises to look at early introduction
of Cancer Drugs Fund»
We also reported how drug companies make oversize eyedrops and vials
of cancer drugs, forcing patients to pay for medication they are unable to use.
One program outlined in the White House spending plan clearly is new: an FDA Virtual Oncology Center of Excellence that will «leverage the combined skills of regulatory scientists and reviewers» to speed the development
of cancer drugs, screening, and diagnostics.
In 2009, BMS took a big risk jumping into the immunotherapy field by acquiring the company Medarex, which brought with it Yervoy, a member of a new class
of cancer drugs.
CALL it the bonfire
of cancer drugs.
With support from pharma, we can refine these molecules over the next 10 - 20 years to develop anti-aging treatments which don't have the adverse effects
of cancer drugs.»
«We first tried a histone methylation inhibitor — a promising new class
of cancer drugs — but that did not restore p16 or had any effect on tumor growth.
A new combination
of cancer drugs delayed disease progression for patients with hormone - receptor - positive metastatic breast cancer, according to a multi-center phase II trial.
INJECTIONS of reovirus, a harmless virus that infects most people at some point but rarely causes symptoms, appears to boost the action
of cancer drugs.
iRGD is therefore potentially useful to optimize the delivery
of cancer drugs by the nanoparticle to the tumor.
Dr Alessandra Ghigo, first author and research fellow in the Department of Molecular Biotechnology and Health Sciences, University of Torino, Italy, said: «Cardiotoxicity
of cancer drugs has become an increasing problem in the last decade due to the increasing success of anticancer therapy and aggressive use of these drugs.
Over its history, Celgene has made a number of diverse acquisitions to expand its portfolio
of cancer drugs, most recently purchasing Abraxane maker Abraxis Pharmaceuticals in 2010.
New research from Dr Ghigo presented for the first time at the Heart Failure Winter Research Meeting shows that solutions to cardiotoxicity
of cancer drugs are within reach.
The authors recommend a set of potential solutions to help control and reduce the high cost
of cancer drugs in the U.S..
«Oncologists reveal reasons for high cost
of cancer drugs in U.S..»
Dr. Rajkumar and his colleague, Hagop Kantarjian, M.D., of MD Anderson Cancer Center, say the average price
of cancer drugs for about a year of therapy increased from $ 5,000 to $ 10,000 before 2000 to more than $ 100,000 by 2012.
Drs. Rajkumar and Kantarjian say other reasons for the high cost
of cancer drugs include legislation that prevents Medicare from being able to negotiate drug prices and a lack of value - based pricing, which ties the cost of a drug to its relative effectiveness compared to other drugs.
«Cost
of cancer drugs varies widely based on who; s paying.»
You state in your article «Trial inequality» that women are under - represented in clinical trials
of cancer drugs, yet do not...
«Improving a better class
of cancer drugs: Chemist has developed a technique to identifying potential cancer drugs that less likely to produce side effects.»
Additionally, the breast cancer resistance protein (Bcrp1), a protein that transports many kinds
of cancer drugs, was reduced by more than 50 % in the livers of both experimental groups.
Antibacterial drugs are sometimes prescribed to treat and prevent infection caused by bone marrow suppression, a side effect
of cancer drugs.
Mice and rats will likely always be used in preclinical trials
of cancer drugs and do offer some significant advantages, Fan said.
Fan also addressed the strengths and limitations of using mice and rats in preclinical trials
of cancer drugs.